% alzhub.org library filter % Source: https://alzhub.org/research?author=Pegueroles+J % 12 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{fortea2024-38710950, author = {Fortea, J. and Pegueroles, J. and Alcolea, D. and Belbin, O. and Dols-Icardo, O. and Vaqué-Alcázar, L. and Videla, L. and Gispert, J. D. and others}, title = {{APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease}}, journal = {Nature medicine}, year = {2024}, doi = {10.1038/s41591-024-02931-w}, pmid = {38710950}, url = {https://doi.org/10.1038/s41591-024-02931-w} } @article{videla2022-35930282, author = {Videla, L. and Benejam, B. and Pegueroles, J. and Carmona-Iragui, M. and Padilla, C. and Fernández, S. and Barroeta, I. and Altuna, M. and others}, title = {{Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome}}, journal = {JAMA network open}, year = {2022}, doi = {10.1001/jamanetworkopen.2022.25573}, pmid = {35930282}, url = {https://doi.org/10.1001/jamanetworkopen.2022.25573} } @article{fortea2018-30172624, author = {Fortea, J. and Carmona-Iragui, M. and Benejam, B. and Fernández, S. and Videla, L. and Barroeta, I. and Alcolea, D. and Pegueroles, J. and others}, title = {{Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study}}, journal = {The Lancet. Neurology}, year = {2018}, doi = {10.1016/s1474-4422(18)30285-0}, pmid = {30172624}, url = {https://doi.org/10.1016/s1474-4422(18)30285-0} } @article{fortea2024-3b742ebe, author = {Fortea, J. and Pegueroles, J. and Alcolea, D. and others}, title = {{APOE4 homozygosity represents a distinct genetic form of Alzheimer's disease}}, journal = {Nature Medicine}, year = {2024} } @article{sampedro2015-26397226, author = {Sampedro, F. and Vilaplana, E. and de Leon, M. J. and Alcolea, D. and Pegueroles, J. and Montal, V. and Carmona-Iragui, M. and Sala, I. and others}, title = {{APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls}}, journal = {Oncotarget}, year = {2015}, doi = {10.18632/oncotarget.5185}, pmid = {26397226}, url = {https://doi.org/10.18632/oncotarget.5185} } @article{zsadanyi2024-39074338, author = {Zsadanyi, S. E. and Morcillo-Nieto, A. O. and Aranha, M. R. and Aragón, I. and Arriola-Infante, J. E. and Vaqué-Alcázar, L. and Montal, V. and Pegueroles, J. and others}, title = {{Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome}}, journal = {Neurology}, year = {2024}, doi = {10.1212/wnl.0000000000209676}, pmid = {39074338}, url = {https://doi.org/10.1212/wnl.0000000000209676} } @article{lleo2021-34262030, author = {Lleó, A. and Zetterberg, H. and Pegueroles, J. and Karikari, T. K. and Carmona-Iragui, M. and Ashton, N. J. and Montal, V. and Barroeta, I. and others}, title = {{Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome}}, journal = {Nature communications}, year = {2021}, doi = {10.1038/s41467-021-24319-x}, pmid = {34262030}, url = {https://doi.org/10.1038/s41467-021-24319-x} } @article{belbin2020-32807227, author = {Belbin, O. and Xiao, M. F. and Xu, D. and Carmona-Iragui, M. and Pegueroles, J. and Benejam, B. and Videla, L. and Fernández, S. and others}, title = {{Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome}}, journal = {Molecular neurodegeneration}, year = {2020}, doi = {10.1186/s13024-020-00398-0}, pmid = {32807227}, url = {https://doi.org/10.1186/s13024-020-00398-0} } @article{montal2021-34309066, author = {Montal, V. and Barroeta, I. and Bejanin, A. and Pegueroles, J. and Carmona-Iragui, M. and Altuna, M. and Benejam, B. and Videla, L. and others}, title = {{Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome}}, journal = {Annals of neurology}, year = {2021}, doi = {10.1002/ana.26178}, pmid = {34309066}, url = {https://doi.org/10.1002/ana.26178} } @article{pegueroles2018-30410669, author = {Pegueroles, J. and Jiménez, A. and Vilaplana, E. and Montal, V. and Carmona-Iragui, M. and Pané, A. and Alcolea, D. and Videla, L. and others}, title = {{Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study}}, journal = {Oncotarget}, year = {2018}, doi = {10.18632/oncotarget.26162}, pmid = {30410669}, url = {https://doi.org/10.18632/oncotarget.26162} } @article{lleo2021-34183050, author = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others}, title = {{VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00861-0}, pmid = {34183050}, url = {https://doi.org/10.1186/s13195-021-00861-0} } @article{lleo2021-870cda97, author = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others}, title = {{VAMP-2 Is a Surrogate Cerebrospinal Fluid Marker of Alzheimer-related Cognitive Impairment in Adults With Down Syndrome}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.21203/rs.3.rs-340117/v1}, url = {https://doi.org/10.21203/rs.3.rs-340117/v1} }